Filing summary
Identity and period: The supplied filing is Schweitzer-Mauduit International, Inc.’s unaudited Form 10-Q for the quarter ended September 30, 2015—not a filing under the name Mativ Holdings, Inc. The company produced specialty papers, reconstituted tobacco and advanced materials. Unless otherwise noted, amounts are in millions of dollars.
Financial performance
| Metric | Three months ended Sept. 30, 2015 | Prior-year quarter | Nine months ended Sept. 30, 2015 | Prior-year nine months |
|---|---|---|---|---|
| Net sales | $184.4 | $204.3 | $554.3 | $612.6 |
| Gross profit / margin | $52.4 / 28.4% | $52.9 / 25.9% | $158.6 / 28.6% | $169.7 / 27.7% |
| Operating profit / margin | $31.8 / 17.2% | $25.2 / 12.3% | $78.3 / 14.1% | $88.8 / 14.5% |
| Net income | $25.8 | $23.0 | $68.0 | $71.2 |
| Diluted EPS | $0.85 | $0.76 | $2.22 | $2.32 |
| Cash from operations | $24.5 | $34.4 | $80.2 | $91.8 |
| Capital spending | $4.9 | $11.1 | $14.0 | $26.2 |
Balance sheet and liquidity: At September 30, cash was $268.5, total debt $400.1 (including $397.0 long-term debt), and stockholders’ equity $460.0. Cash less total debt implies net debt of about $131.6. The company reported $111.8 of availability under its then-existing credit facility and $28.7 available under overdraft facilities and other lines. $260.3 of cash was held by foreign subsidiaries. Total debt to capital was 46.5%, versus 47.4% at December 31, 2014. The company was in compliance with its existing credit covenants.
Material changes versus prior periods
- Quarterly sales fell 9.7%; nine-month sales fell 9.5%. Management attributed the declines primarily to unfavorable currency translation—$22.0 in the quarter and $61.2 year to date, mainly from a weaker euro. Tobacco-related segments also faced lower prices and volumes; Reconstituted Tobacco was additionally affected by unfavorable product mix.
- Advanced Materials & Structures sales rose 26.1% in the quarter and 26.8% year to date, mainly reflecting the December 2014 acquisitions. Its nine-month sales also included $1.5 of organic growth.
- Quarterly operating profit rose $6.6, led by Paper’s improved utilization, product mix and lower manufacturing costs, and lower unallocated expenses. Year-to-date operating profit fell $10.5: Reconstituted Tobacco declined $14.4, while Advanced Materials & Structures increased $4.7.
- Year-to-date gross margin improved, but operating margin declined. Net income increased in the quarter but decreased year to date. Year-to-date other income included a $4.3 gain on water rights and a $1.0 reversal of acquisition-related contingent consideration.
- Other comprehensive loss was $61.7 for the first nine months, largely reflecting foreign currency translation and derivative losses; this reduced equity to $460.0 from $489.0 at year-end 2014.
Outlook, risks and unusual items
- No numerical full-year revenue or EPS forecast is provided. Management expected tobacco-paper volumes to face ongoing industry attrition and pricing pressure. Based on early customer indications, it expected 2016 Reconstituted Tobacco sales volumes to be at least 10% below originally planned 2015 volumes, with weakness potentially continuing through 2017.
- Potential offsets include development of reconstituted tobacco for heat-not-burn products, growth in the China joint venture and further adoption of lower-ignition-propensity standards. Timing and commercial outcomes remain uncertain.
- On October 28, 2015, after quarter-end, the company completed its $280 cash acquisition of Argotec. On that date it also replaced its unsecured $500 revolving facility with secured credit facilities totaling $1 billion: a $650 revolving facility and $350 of term loans. It borrowed $350 under the term loans and $329.5 under the revolver. The acquisition and financing materially changed the company’s post-quarter debt and leverage profile.
- Year-to-date restructuring and impairment expense was $10.5, including French restructuring costs and write-downs of equipment at the mothballed Philippines RTL site. Assets held for sale included $5.8 at September 30.
- Brazil tax disputes remained unresolved. The company reported approximately $10 million at issue in the Raw Materials Assessment still under appeal, plus electricity-related assessments of approximately $12 million in total. No liability was recorded; management believed the matters would be resolved in its favor but gave no assurance of outcome. The Supreme Court of Brazil denied the State’s appeal in a separate approximately $16 million assessment on October 30, 2015; further proceedings remained possible.
- Other key risks cited include declining cigarette consumption, customer pricing and volume pressure, foreign-exchange volatility, commodity and energy costs, oil/gas/mining market weakness, acquisition integration and synergy execution, and litigation over lower-ignition-propensity technology. The company disclosed no material change to previously reported risk factors.
Important facts for investors to verify
- Confirm the issuer and filing identity: the text is for Schweitzer-Mauduit International, Inc., despite the request metadata naming Mativ Holdings, Inc.
- Assess whether tobacco volume declines, especially the indicated Reconstituted Tobacco weakness, are offset by pricing, cost actions, new products or advanced-materials growth.
- Review the pro forma effect of Argotec and the October financing on debt, interest expense, covenant headroom and integration costs; the filing does not provide post-transaction pro forma earnings or leverage.
- Track currency effects and the concentration of cash held overseas, alongside working-capital needs and cash generation.
- Monitor outcomes and potential financial exposure from the Brazilian tax assessments, Philippines asset disposal and German intellectual-property proceedings.